Relafen 750, pharmacologically known as naproxen, represents a important case study from a pharmacological pharmacy standpoint. It's read more exhibits its medicinal effect primarily by blocking the activity of cyclooxygenase (COX) enzymes, specifically COX-2, thereby suppressing prostaglandin production . The targeted inhibition of COX-2, compared